prevents bleeding in those with a certain type of blood clotting disorder. Tell your doctor before using this medication if you have a history of blood clots.
Catridecacog is a prescription medication used to prevent bleeding in people with a rare blood clotting disorder known as congenital Factor XIII A-subunit deficiency. This medication replaces an important protein necessary for normal clotting.
Catridecacog comes in an injectable form to be given directly into a vein (IV) by a healthcare professional. In some cases, patients can be taught to properly administer this medication.
Common side effects include headache and pain at the site of injection.
How was your experience with Catridecacog?
Catridecacog Cautionary Labels
Uses of Catridecacog
Catridecacog is a prescription medication used to prevent bleeding in patients with congenital factor XIII A-subunit deficiency.
Catridecacog Brand Names
Catridecacog may be found in some form under the following brand names:
Catridecacog Drug Class
Catridecacog is part of the drug class:
Side Effects of Catridecacog
In clinical trials, the most frequent adverse drug reactions were non-neutralizing antibodies. The antibodies had no inhibitory effect and the patients did not experience any adverse events or bleeding in association with these antibodies.
Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take factor VIIa.
This is not a complete list of catridecacog drug interactions. Ask your doctor or pharmacist for more information.
Serious side effects can occur including:
- hypersensitivity reactions. This medication is a recombinant protein and it may cause allergic reactions including anaphylactic reaction (a severe allergic response). Tell your healthcare provider if you have signs of an allergic reaction including hives, rash, tightness of the chest, wheezing, low blood pressure and anaphylaxis.
- thrombosis (blood clot formation). Increased levels of activated rFXIII may increase the risk of thrombosis. In case of predisposition to conditions of thrombosis, caution should be exercised due to the fibrin-stabilizing effect of this medication.
Catridecacog Food Interactions
Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of catridecacog, there are no specific foods that you must exclude from your diet when receiving this medication.
Before taking catridecacog, tell your doctor about all of your medical conditions. Especially tell your doctor if you:
- If you are pregnant, think you may be pregnant or planning to become pregnant. It is not known if catridecacog can harm you or your unborn baby.
- Labor and Delivery: It is not known if catridecacog is safe and effective during labor and delivery.
- Breast feeding: It is not known if catridecacog passes into your breast milk.
- If you have a history of blood clots.
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.
Catridecacog and Pregnancy
Tell your healthcare provider if you are pregnant or planning to become pregnant. It is not known if this medication will harm your unborn baby. Catridecacog should be used only if the benefits clearly outweigh the risks.
Catridecacog and Lactation
Tell your healthcare provider if you are breastfeeding. It is not known if this medication is excreted in human breast milk or if it will harm your nursing baby. The decision to continue or discontinue breastfeeding or catridecacog therapy should be based on benefits to child and mother.
- Reconstituted (prepared) catridecacog should be used immediately.
- If it is not used immediately, it should be used within 3 hours if stored at room temperature. After this period discard it.
- It should be used within 24 hours if stored in the refrigerator at 2ºC–8ºC. After this period discard it.
- Do not store reconstituted catridecacog in a syringe.
- Do not freeze reconstituted catridecacog.
Take this medication exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.
The dose your doctor recommends may be based on the following your weight.
The recommended dose/dose range of catridecacog (Tretten) is 35 IU/kg dose.
If you take too much catridecacog, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.
If catridecacog is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.
- Store in refrigerator (2ºC–8ºC).
- Store in the original package in order to protect from light.
- Do not freeze to prevent damage to the solvent vial.